A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)

NCT03460990 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: VX-659/TEZ/IVA
DRUG: TEZ/IVA
DRUG: IVA
DRUG: Placebo
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated